{
  "patent_number": "US 12735501",
  "country": "US",
  "title": "Easier Injections for Multiple Myeloma Cancer Treatment",
  "original_title": "Subcutaneous formulations of daratumumab and their uses in treating multiple myeloma",
  "summary": "This patent describes specific liquid mixtures (formulations) of anti-CD38 antibodies designed to be injected just under the skin for treating multiple myeloma, making administration simpler than traditional intravenous methods.",
  "what_it_does": "This patent describes specific ways to create a liquid medicine (a 'formulation') containing anti-CD38 antibodies so it can be injected just under the skin ('subcutaneously'). The goal is to make it easier to give this medicine, which is used to treat a type of blood cancer called multiple myeloma. While the specific claims are not available, the invention focuses on the precise mix of ingredients that allows the anti-CD38 antibody to be delivered effectively and safely via a subcutaneous shot, rather than through a vein. For example, instead of a long infusion at a clinic, a patient could receive a quicker injection.",
  "what_it_does_not_cover": [
    "Does not cover intravenous (IV) formulations of anti-CD38 antibodies, only those designed for subcutaneous injection.",
    "Does not cover formulations of other types of antibodies or drugs that are not anti-CD38 antibodies.",
    "Does not cover treatments for cancers other than multiple myeloma, as specified in the abstract.",
    "Does not cover the anti-CD38 antibody molecule itself, only its specific preparation for subcutaneous use.",
    "Does not cover methods of treatment that do not involve administering the specific subcutaneous formulation."
  ],
  "filed": "2026-01-14",
  "granted": "2026-09-15",
  "expires": null,
  "status": "active",
  "holder": null,
  "holder_url": null,
  "inventors": [],
  "times_cited": 0,
  "tags": [
    "biotech",
    "pharmaceutical",
    "oncology",
    "drug_delivery"
  ],
  "abstract": "The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.",
  "url": "https://patentbrief.org/patent/us/12735501/subcutaneous-formulations-of-daratumumab-and-their-uses-in-treating-multiple",
  "markdown_url": "https://patentbrief.org/patent/us/12735501/subcutaneous-formulations-of-daratumumab-and-their-uses-in-treating-multiple/md",
  "google_patents_url": "https://patents.google.com/patent/US12735501",
  "relatedPatents": []
}